334 related articles for article (PubMed ID: 22834409)
21. Nanotechnology in Insulin Delivery for Management of Diabetes.
Bahman F; Greish K; Taurin S
Pharm Nanotechnol; 2019; 7(2):113-128. PubMed ID: 30907328
[TBL] [Abstract][Full Text] [Related]
22. Antiretroviral nanoparticles: an extended drug delivery modality.
Destache CJ; Goede M; Belgum T
Ther Deliv; 2010 Sep; 1(3):383-6. PubMed ID: 22816141
[TBL] [Abstract][Full Text] [Related]
23. Peptides for specific intracellular delivery and targeting of nanoparticles: implications for developing nanoparticle-mediated drug delivery.
Delehanty JB; Boeneman K; Bradburne CE; Robertson K; Bongard JE; Medintz IL
Ther Deliv; 2010 Sep; 1(3):411-33. PubMed ID: 22816144
[TBL] [Abstract][Full Text] [Related]
24. Multifunctional Delivery Systems for Advanced oral Uptake of Peptide/Protein Drugs.
Park JW; Kim SJ; Kwag DS; Kim S; Park J; Youn YS; Bae YH; Lee ES
Curr Pharm Des; 2015; 21(22):3097-110. PubMed ID: 26027575
[TBL] [Abstract][Full Text] [Related]
25. Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: Interactions with mucin and biomembrane models.
Andreani T; Miziara L; Lorenzón EN; de Souza AL; Kiill CP; Fangueiro JF; Garcia ML; Gremião PD; Silva AM; Souto EB
Eur J Pharm Biopharm; 2015 Jun; 93():118-26. PubMed ID: 25843239
[TBL] [Abstract][Full Text] [Related]
26. Enhanced intestinal permeability and oral bioavailability of enalapril maleate upon complexation with the cationic polymethacrylate Eudragit E100.
Ramírez-Rigo MV; Olivera ME; Rubio M; Manzo RH
Eur J Pharm Sci; 2014 May; 55():1-11. PubMed ID: 24456933
[TBL] [Abstract][Full Text] [Related]
27. Novel strategies in the oral delivery of antidiabetic peptide drugs - Insulin, GLP 1 and its analogs.
Ismail R; Csóka I
Eur J Pharm Biopharm; 2017 Jun; 115():257-267. PubMed ID: 28336368
[TBL] [Abstract][Full Text] [Related]
28. Drug development of intranasally delivered peptides.
Campbell C; Morimoto BH; Nenciu D; Fox AW
Ther Deliv; 2012 Apr; 3(4):557-68. PubMed ID: 22834082
[TBL] [Abstract][Full Text] [Related]
29. Challenges and advances in nanoparticle-based oral insulin delivery.
Ramesan RM; Sharma CP
Expert Rev Med Devices; 2009 Nov; 6(6):665-76. PubMed ID: 19911877
[TBL] [Abstract][Full Text] [Related]
30. Inhalative nanomedicine--opportunities and challenges.
Bur M; Henning A; Hein S; Schneider M; Lehr CM
Inhal Toxicol; 2009 Jul; 21 Suppl 1():137-43. PubMed ID: 19558246
[TBL] [Abstract][Full Text] [Related]
31. Formulation strategies to improve oral peptide delivery.
Maher S; Ryan B; Duffy A; Brayden DJ
Pharm Pat Anal; 2014 May; 3(3):313-36. PubMed ID: 24998290
[TBL] [Abstract][Full Text] [Related]
32. Oral colon-specific drug delivery of protein and peptide drugs.
Sinha V; Singh A; Kumar RV; Singh S; Kumria R; Bhinge J
Crit Rev Ther Drug Carrier Syst; 2007; 24(1):63-92. PubMed ID: 17430100
[TBL] [Abstract][Full Text] [Related]
33. Nanocarriers.
Torchilin VP
Pharm Res; 2007 Dec; 24(12):2333-4. PubMed ID: 17934800
[TBL] [Abstract][Full Text] [Related]
34. A review of biodegradable polymeric systems for oral insulin delivery.
Luo YY; Xiong XY; Tian Y; Li ZL; Gong YC; Li YP
Drug Deliv; 2016 Jul; 23(6):1882-91. PubMed ID: 26066036
[TBL] [Abstract][Full Text] [Related]
35. Transmembrane transport of peptide type compounds: prospects for oral delivery.
Lipka E; Crison J; Amidon GL
J Control Release; 1996 May; 39(2-3):121-9. PubMed ID: 11539926
[TBL] [Abstract][Full Text] [Related]
36. Developments in polymeric devices for oral insulin delivery.
Babu VR; Patel P; Mundargi RC; Rangaswamy V; Aminabhavi TM
Expert Opin Drug Deliv; 2008 Apr; 5(4):403-15. PubMed ID: 18426382
[TBL] [Abstract][Full Text] [Related]
37. New views and insights into intracellular trafficking of drug-delivery systems by fluorescence fluctuation spectroscopy.
Coppola S; Caracciolo G
Ther Deliv; 2014 Feb; 5(2):173-88. PubMed ID: 24483195
[TBL] [Abstract][Full Text] [Related]
38. An efficient pH sensitive oral insulin delivery system enhanced by deoxycholic acid.
Zhao L; Ding J; He P; Xiao C; Tang Z; Zhuang X; Chen X
J Control Release; 2011 Nov; 152 Suppl 1():e184-6. PubMed ID: 22195840
[No Abstract] [Full Text] [Related]
39. Nanoparticle delivery strategies to target doxorubicin to tumor cells and reduce side effects.
Wang Y; Wei X; Zhang C; Zhang F; Liang W
Ther Deliv; 2010 Aug; 1(2):273-87. PubMed ID: 22816133
[TBL] [Abstract][Full Text] [Related]
40. Using peptides to increase transport across the intestinal barrier.
Sánchez-Navarro M; Garcia J; Giralt E; Teixidó M
Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):355-366. PubMed ID: 27155131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
